If you have a higher A1C or if metformin alone is not enough to meet your A1C and blood sugar goals, your doctor may prescribe a combination of medications. Each type of diabetes medication can ...

When monotherapy with oral antidiabetic agents fails, combination therapy with repaglinide plus metformin has been demonstrated to be safe and effective in the treatment of T2DM. Type 2 diabetes ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

When you take more than one drug to control your type 2 diabetes, that’s called combination therapy. You and your doctor should work together to find the best mix for you. Some drugs control ...

The FDA has approved Novo Nordisk’s Xultophy and Sanofi’s Soliqua on the same day, pitching the rival diabetes combination into ... FDA approved labels of the drugs, and neither have on ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity ... destroying the protective shield around ... Treatment with a combination of haloperidol and lorazepam reduced ...

The Multidisciplinary Committee (MDC) of experts with the National Pharmaceutical Pricing Authority (NPPA) has recommended retail price of combinations containing diabetes drug empagliflozin ...

EASD 2024 participants are looking for the hottest efficacy data to make predictions on the next trend in the metabolic space ...

Jennifer Green, MD, of Duke University, explained that while CMS-negotiated drug prices under the Inflation Reduction Act (IRA) may not immediately lower patients' costs, they could improve access to ...

Treatment with a combination of haloperidol and lorazepam ... semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. ... A drug, broadly speaking, is any substance that ...

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

For those antidiabetic drugs that are metabolized via the CYP450 ... the manufacturer recommends that a repaglinide-metformin combination tablet should be avoided in patients with hepatic impairment.